We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
27 Jul 2020 - 30 Jul 2020

Middle East IVF Market Driven by High Demand for IVF and Related Treatments

By LabMedica International staff writers
Posted on 23 Jan 2019
Print article
Image: The global IVF market is currently estimated to be worth USD 10-12 billion (Photo courtesy of iStock).
Image: The global IVF market is currently estimated to be worth USD 10-12 billion (Photo courtesy of iStock).
The global In Vitro Fertilization (IVF) market is currently estimated to be worth between USD 10 billion to USD 12 billion, while the IVF market in Middle East & North Africa (MENA) is estimated to be approximately USD 1 billion, indicating a high demand for IVF and related treatments in the region.

These are the findings in a new report published by Colliers International (Toronto, Canada) as part of the MEDLAB Market Report series ahead of MEDLAB 2019, which took place from February 4-7, 2019, at the Dubai World Trade Centre. MEDLAB Exhibition & Congress 2019, which is organized by Informa Exhibitions, welcomed more than 19,600 medical laboratory trade professionals and 670+ exhibitors from 46 countries in an effort to develop the value of laboratory medicine in shaping the future of healthcare and to provide advanced medical laboratory techniques for better health.

According to the latest report by Colliers International, the population in MENA has increased from over 100 million in 1950 to 380 million in 2017 and is expected to increase to 700 million by 2050, although the overall fertility rates in the region have decreased from seven children per women in 1960 to just three in 2017. Infertility in the MENA region is 15% or higher, as compared to 10% worldwide, with male infertility being a growing problem and occurring in approximately 50% of the cases in the GCC and Middle East. This can be attributed to lifestyle, diabetes, obesity and genetics related factors, as GCC countries have one of the highest diabetic and obesity rates in the world.

However, new innovations and improved testing techniques are gradually creating paradigm shifts in the field of assisted reproductive technology. In particular, increased focus on pre-marital screening for consanguineous (relatives) couples and development of new genetic tests for screening of embryos greatly improves the chance of minimizing certain genetic diseases common in this region.

“The Carrier Genetic Test (CGT) helps to determine the risk of having a child with a genetic disease. Anyone, without knowing, can be a carrier of one or more recessive mutations, but some couples have higher possibilities to carry the same genes,” said Dr. Laura Melado, Specialist – Obstetrics & Gynecology, IVF, IVI Middle East Fertility Clinic, Abu Dhabi, UAE, who will be speaking at the Cytogenetics & IVF Conference during MEDLAB 2019, commented. “When this happens Pre-implantation Genetic Testing (PGD) can be done for the embryos as part of the fertility treatment to help the couples to deliver healthy babies.”

“IVF is not only sought after locally but is one of the leading treatments undertaken by medical tourists in the UAE, especially in Dubai. Based on Colliers’ discussions with leading operators, medical tourism accounts for 10% to 15% of the IVF patient volumes,” said Mansoor Ahmed, Director Healthcare, Education & PPP for MENA Region at Colliers International.

Related Links:
Colliers International

Print article



view channel
Image: The Idylla system is a fully-automated, real-time polymerase chain reaction (PCR) based molecular testing system designed to offer results in a minimal amount of time (Photo courtesy of Biocartis).

Rapid Genomic Profiling of Colon Cancers Improves Therapy Selection

Colorectal cancer is a malignant tumor arising from the inner wall of the large intestine (colon) or rectum. Colorectal cancer is the third leading cause of cancer in both men and women in the USA.... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.